Breast Cancer in Men

Ravi, A.; Bang, Heejung; Karsif, Karen; Nori, Dattatreyudu

doi:10.1177/1557988311416495

Cited by 14 publications

(12 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Breast cancer has similar prognostic factors and behaviour in men and women [12] [168], which means that a higher degree of differentiation of the tumour is associated with a poorer prognosis; 2) Clinical cancer stage [40] [87] [167]- [169] i.e. tumours at higher stages produce a worse prognosis; 3) The hormone receptor status [10] [174], which means that larger tumours are correlated with shorter 5-year survival rates ( Table 3); 5) The most documented factor i.e.…”

Section: Prognostic Factorsmentioning

confidence: 99%

Male Breast Cancer Clinical Features, Risk Factors, and Current Diagnostic and Therapeutic Approaches

Darkeh¹,

Azavedo²

2014

IJCM

View full text Add to dashboard Cite

Objective: To review presentation, diagnosis, treatment and prognosis of male breast cancer. Method: A systematic review of the English language literature between 1990 and 2013 was conducted to identify studies relevant to the objective. Searches were carried out on the database PubMed, by using the title term "male breast cancer". Results: The majority of male patients present with a painless, firm, subareolar lump. Experience of male breast imaging is good but limited. However, there is no definitive therapeutic algorithm. Men are often treated with mastectomy instead of breast conserving surgery and mostly tamoxifen is used as an adjuvant therapy. The most important prognostic factors are tumor size and lymph node status in the armpit. Conclusion: More increased awareness and further research are needed to improve the diagnosis and treatment of this disease.

show abstract

Section: Prognostic Factorsmentioning

confidence: 99%

Male Breast Cancer Clinical Features, Risk Factors, and Current Diagnostic and Therapeutic Approaches

Darkeh¹,

Azavedo²

2014

IJCM

View full text Add to dashboard Cite

show abstract

“…In rich countries which are better organized and equipped, patients enjoy a well codified set of treatments. For example, in the USA, patients of Akkamma’s series were treated with surgery (95%), chemotherapy (54.5%), hormonal therapy (61%), and radiation therapy (34%) [ 9 ]. In France, in Oger’s series, patients were also treated by surgery (98%), chemotherapy (37%), hormonal therapy (92%), and radiation therapy (75%) [ 10 ].…”

Section: Discussionmentioning

confidence: 99%

“…However, the surgery of male breast cancer has become less and less invasive. The most recent studies mention lumpectomy and sentinel lymph node technique which give the same therapeutic results as radical surgery for tumors with sizes T1 and T2 [ 9 , 18 , 27 , 28 ]. The sentinel lymph node technique would enable like in women, reduce morbidity related to axillary dissection for small tumors of less than 2.5 cm [ 7 , 17 ].…”

Section: Discussionmentioning

confidence: 99%

“…Modeled on the treatment of female breast cancer, the treatment of male breast cancer is done according to the tumor size [ 2 , 4 ]. In western countries, patients are treated with surgery, chemotherapy, hormonal therapy and radiation therapy [ 9 , 10 ] while in Africa, surgery remains the only treatment in almost all cases [ 7 , 8 , 11 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Male breast cancer: diagnosis stages, treatment and survival in a country with limited resources (Burkina Faso)

et al. 2018

View full text Add to dashboard Cite

BackgroundMale breast cancer is a rare and less known disease. Therapeutic modalities affect survival. In Burkina Faso, male breast cancers are diagnosed in everyday practice, but the prognosis at short-, middle-, and long-term remains unknown. The objective of this study is to study the diagnosis stages, therapeutic modalities, and 5-year survival in male breast cancer at the General Surgery Unit of Yalgado Ouedraogo University Hospital from 1990 to 2009.MethodsA cohort longitudinal study concerning cases of breast cancer diagnosed in man. Survival was assessed using the Kaplan–Meier method and survival curves were compared through the LogRank test.ResultsFifty-one cases of male breast cancer were followed-up, i.e., 2.6% of all breast cancers. Stages III and IV represented 88% of cases. Eleven patients (21.6%) were at metastatic stage. Patients were operated in 60.8% of cases. The surgery included axillary dissection in 25 (80.6%) out of 31 cases. Lumpectomy was performed on 6.5% of patients (2 cases). Fifteen (29.4%) and 11 (21.6%) patients underwent chemotherapy and hormonal therapy, respectively. The FAC protocol was mostly used. Radiation therapy was possible in two cases. The median deadline for follow-up was 14.8 months. A local recurrence was noticed in 3.2% of cases. The overall 5-year survival rate was 49.9%. The median survival was over 5 years for stages I and II. It was 54 down to 36 months for stages III and IV.ConclusionDiagnosis is late. The lack of immunohistochemistry makes it difficult to define the proportion of their hormonal dependence. Surgery is the basic treatment. Five-year survival is slow and the median survival depends on the diagnosis stage. It can be improved through awareness-raising campaigns and the conduct of individual screening.

show abstract

“…While studies have suggested men's survival from breast cancer is poorer than women's, when adjustment is made for stage at presentation and age men fare as well or even slightly better [2,8,9]. Men tend to present at a later stage of disease [10] and are more likely to undergo mastectomy (74% versus 19% breast-conserving therapy (BCT)) [11]. This tendency to delayed presentation is attributed to lower perceived risk of cancer, symptoms other than a lump, and presentations are often precipitated by an appointment for an unrelated condition or by instruction to seek help by a relative or partner [12].…”

Section: Male Breast Cancermentioning

confidence: 99%

Psychological Impact of Male Breast Disorders: Literature Review and Survey Results

Kipling

Ralph

Callanan³

2014

Breast Care

View full text Add to dashboard Cite

Background: Referrals of men to breast assessment clinics are increasing. While most of the men will have benign disease, some of them will have breast cancer. Whichever pathology they have, men should be offered a service tailored to their needs, rather than being ‘shoe-horned' into a service designed to care for women. This paper explores the psychological impact on men of their condition and of attending a breast assessment clinic. Methods: The literature regarding male experience of breast problems is reviewed, and screening for psychological morbidity is discussed. Results of a survey regarding an all-male breast assessment clinic are reported, with a plan for future research. Results: Many of the 78 men surveyed described negative feelings relating to their condition although they did not want to be seen in an all-male breast assessment clinic if that meant a longer wait. Men reported feelings of anxiety, embarrassment, emasculation and even depression regarding their condition. Conclusions: Men are distressed by gynaecomastia and need psychological support for any breast-related presentation. More formalised research into this area is needed, although the men's distress does not translate into the desire to attend an all-male assessment clinic if this means a longer wait before being seen.

show abstract

Breast Cancer in Men

Cited by 14 publications

References 29 publications

Male Breast Cancer Clinical Features, Risk Factors, and Current Diagnostic and Therapeutic Approaches

Male Breast Cancer Clinical Features, Risk Factors, and Current Diagnostic and Therapeutic Approaches

Male breast cancer: diagnosis stages, treatment and survival in a country with limited resources (Burkina Faso)

Psychological Impact of Male Breast Disorders: Literature Review and Survey Results

Contact Info

Product

Resources

About